Pharmacologic interventions for the prevention and treatment of osteoporosis include vitamin and mineral supplementation, hormone replacement therapy, bisphosphonates, calcitonin, and selective ...

Osteoporosis is a silent disease that can have devastating consequences for women. Although it primarily affects postmenopausal women, women of all ages should receive extensive education and ...

Osteoporosis Prevention in Young Women. The National Osteoporosis Foundation recommends that women aged 18–50 years should consume 1000 mg of calcium and 600 IU of vitamin D daily.

The prevalence of osteoporosis in the Spanish female population, as in other European countries, [] is about 13%, [] but this percentage increases to 35% in women aged ≥50 years. [] Despite this ...

2003年5月1日 · Current approaches to the prevention, detection, treatment, and monitoring of postmenopausal osteoporosis are discussed. In the United States, 44 million men and women ages 50 years or older have ...

2022年9月22日 · Osteoporosis Prevention . After stopping some prevention therapies for GIOP, a high risk of bone loss or fracture still persists, according to Linda Russell, MD, director of the Osteoporosis and ...

2003年5月1日 · The following goals are appropriate for osteoporosis prevention and treatment: Prevention of fractures, Optimization of skeletal development and maximization of peak bone mass at skeletal maturity,

Treatment & Prevention of Glucocorticosteroid-induced Osteoporosis . Owing to a much lower mechanical bone strength than would appear to be the case from observing BMD and a significant increase ...

However, osteoporosis associated with chronic steroid therapy is an important and often underestimated problem. ... especially with regard to effective counteraction and prevention rules, not only ...

2003年5月1日 · Once-weekly alendronate has FDA-approved labeling for use at a dosage of 35 mg/week for prevention of osteoporosis and 70 mg/week for treatment. Risedronate is also approved at a dose of 35 mg ...